We are international
Donate
publications TEXT SIZE   
the understanding series    back

Understanding Adherence to Oral Cancer Therapy

Understanding Adherence to Oral Cancer Therapy is intended to help myeloma patients and their healthcare providers work together to overcome any and all obstacles to adherence to safe and effective oral cancer therapy.

05.14.13

“Adherence” to an oral therapy means that in order to achieve the best results:

  • You take the correct medicine.
  • You take the correct dose.
  • You take your medication in the correct manner.
  • You take your medication for the prescribed length of time.
  • No doses are taken in the wrong quantity.
  • No doses are taken at the wrong time.
  • No doses are missed.
  • No extra doses are taken.

In the case of myeloma, there are currently three FDA-approved treatments available to myeloma patients that are taken orally: Thalomid® (thalidomide), Revlimid® (lenalidomide), and Pomalyst® (pomalidomide).

Several other oral therapies for myeloma are currently in clinical trials. Oral therapy now plays, and will continue to play, an important role in treating myeloma. Adhering to the doctor’s treatment plan – and seeking help for any possible problems that could cause deviation from that plan – are crucial to achieving the best possible treatment outcome.

 related videos
 related articles
ASCO 2013: Dr. Jagannath - Pomalidomide (POM) with or without low-dose dexamethasone (LoDEX) in patients (Pts) with relapsed and refractory multiple myeloma (RRMM): MM-002 phase II age subgroup analysis.
"Understanding Health Disparities in Cancer: The Case of Multiple Myeloma"
Understanding Serum Free Light Chain and Serum Heavy/Light Chain Assays
ASCO 2013: Dr. Jagannath - Pomalidomide (POM) with or without low-dose dexamethasone (LoDEX) in patients (Pts) with relapsed and refractory multiple myeloma (RRMM): MM-002 phase II age subgroup analysis.
Best of ASH 2013: What Patients Need to Know
BLACK SWAN RESEARCH INITIATIVE™ DONOR LEVELS
BLACK SWAN RESEARCH INITIATIVE™ MEDIA CONTACT
BRAZIL WORKSHOP
California Support Group Leader’s Testimony Makes Huge Difference
Cancer Awareness Bracelets
IMF Nurse Leadership Board (NLB) Survivorship Care Plan for Mutliple Myeloma published in the Clinical Journal of Oncology Nursing.
International Myeloma Foundation (IMF)
Flow Workshop Presentations
July 18-19, 2014
International Myeloma Foundation Mission Statement
Mensajero del Mieloma - Otoño 2012 - #903
Michael and Robin Tuohy of Connecticut Help to Pass State Oral Parity Bill
Pomalidomide News: Promising Results Increase Chances of Early Drug Approval
Raise Your Voice Web Series
Sign up TODAY for Advocacy Training Two-Part Online Series!
Supreme Court Upholds Affordable Care Act
The International Myeloma Foundation Applauds Wisconsin Gov. Scott Walker for Signing SB 300 (The Cancer Treatment Fairness Act) into Law